Results 151 to 160 of about 314,969 (284)

Do drugs approved via expedited approval pathways have therapeutic advantages? A systematic review and meta‐analysis

British Journal of Clinical Pharmacology, EarlyView.
Regulators use expedited approval pathways to speed market approval and patient access to promising new drugs. However, there is uncertainty about whether these pathways are successful in approving drugs with significant therapeutic advantages. This systematic review aims to examine the safety, effectiveness and cost‐effectiveness of drugs approved via
Ashleigh Hooimeyer, Eliza J. McEwin, Zhicheng Wang, Joel Lexchin, Barbara Mintzes   +4 more
wiley   +1 more source

Enhancing Named Entity Recognition for immunology and immune-mediated disorders. [PDF]

Front Immunol
Chen S, Che J, Sun M, Wang Y.
europepmc   +1 more source

The evolving therapeutic landscape of spinal muscular atrophy – A scoping review of investigational agents, emerging delivery technologies and strategic innovations

British Journal of Clinical Pharmacology, EarlyView.
Spinal muscular atrophy (SMA) is a severe neuromuscular disease with emerging therapeutic complexity. This review aims to systematically map the global pipeline of investigational treatments for SMA. Using ClinicalTrials.gov and complementary international registries, we identified 21 planned or ongoing interventional trials from 2020 to 2025 targeting
Andrej Belančić, Patrick Eustaquio, Elvira Meni Maria Gkrinia, Ivana Stević, Eugen Javor, Yun Wah Lam, Slobodan Janković, Dinko Vitezić   +7 more
wiley   +1 more source

ANCHOLIK-NER: A benchmark dataset for Bangla regional named entity recognition. [PDF]

PLoS One
Paul B, Preotee FF, Sarker S, Refat SR, Islam S, Muhammad T, Hoque MA, Manzoor S.   +7 more
europepmc   +1 more source

Listening to Hong Kong children's perspectives through pretend play

British Educational Research Journal, EarlyView.
Abstract Quality in early childhood education and care (ECEC) has become an increasing concern in recent years. The issue has been regularly discussed by different stakeholders. However, the rising concern regarding quality in ECEC has not seriously taken into account children's perspectives.
Suzannie K. Y. Leung
wiley   +1 more source

Leveraging large language models for rare disease named entity recognition. [PDF]

PLOS Digit Health
Xi NM, Deng Y, Wang L.
europepmc   +1 more source

The future in a bubble: Supporting Finnish early childhood professionals working in diverse settings

British Educational Research Journal, EarlyView.
Abstract The purpose of this study was to contribute to the knowledge about early childhood education and care (ECEC) personnel's perception of the support structures that are most effective in assisting them in their work with culturally and linguistically diverse children.
Alexandra C. Anton, Juli‐Anna Aerila, Elizabeth A. Steed   +2 more
wiley   +1 more source

WBA: Word Boundary Attention for Chinese Named Entity Recognition. [PDF]

PLoS One
Xu Z.
europepmc   +1 more source

International student agency in academic self‐formation: Mobility as agency situated within knowledge structures

British Educational Research Journal, EarlyView.
Abstract With growing attention to student agency in academic and policy discourse, international education has become a prominent context for examining how students navigate new cultural, academic, linguistic and social environments. However, much of this discussion attributes student agency to the ‘international’ aspect, while overlooking the ...
Soyoung Lee
wiley   +1 more source

MULTITHREAD IN NAMED ENTITY RECOGNITION [PDF]

International Journal of Intelligent Computing and Information Sciences, 2016
Z. Rabea, M. Abu Elsoud, M. Rashed
openaire   +1 more source